Amundi
IART icon

Amundi’s Integra LifeSciences IART Stock Holding History

Amundi’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$183K Buy
19,430
+8,681
+81% +$95.3K ﹤0.01% 1898
2025
Q4 		$134K Sell
10,749
-319
-3% -$4.24K ﹤0.01% 1791
2025
Q3 		$160K Hold
11,068
– – ﹤0.01% 1562
2025
Q2 		$150K Buy
11,068
+11,004
+17,194% +$160K ﹤0.01% 1635
2025
Q1 		$1.28K Buy
64
+36
+129% +$847 ﹤0.01% 2010
2024
Q4 		$623 Buy
+28
New +$611 ﹤0.01% 2086
2023
Q1 		– Sell
-1,063
Closed -$61.8K – 2080
2022
Q4 		$61.8K Buy
+1,063
New +$54.1K ﹤0.01% 1670

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Amundi's IART Position: Q1 2026 in Review

Amundi increased its Integra LifeSciences (IART) stake by 81% in Q1 2026, buying an estimated $95.3K and bringing the position to 19,430 shares worth $183K. The position accounts for ﹤0.01% of the portfolio, ranked #1898.

Amundi first reported a position in IART in Q4 2022 and has held it in 7 quarters since. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Amundi held 19,430 shares of Integra LifeSciences worth $183K as of Q1 2026.
  • Amundi bought 8,681 Integra LifeSciences shares in Q1 2026, an estimated $95.3K.
  • Integra LifeSciences made up ﹤0.01% of Amundi's portfolio in Q1 2026, its #1898 holding.
  • Amundi first reported a position in Integra LifeSciences in Q4 2022 and has held it in 7 quarters since.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.